Por: The Hill Health August 05, 2023
The Centers for Disease Control and Prevention (CDC) officially recommended the first preventive Respiratory syncytial virus (RSV) treatment for infants on Thursday, shortly after a key panel endorsed the product. CDC Director Mandy Cohen adopted the guidance recommended by the Advisory Committee on Immunization Practices (ACIP) on Thursday for the administration of nirsevimab, or Beyfortus. since the start of the unwinding. This development may... + full article
CBS News USA Politics August 04, 2023
Many babies should get a shot soon after birth to protect them from RSV, or respiratory syncytial virus, the Centers for Disease Control and Prevention said Thursday. The recommendation clears the way for a new option experts have hailed as a historic advance to curb the for... + más
NFL Playoff Scenarios | ABC News
Le Krewe du Roi celebrates the state at 58th annual Mardi Gras Ball | The Advocate
New York Post USA Life July 18, 2023
The Food and Drug Administration on Monday approved a new drug, Beyfortus (nirsevimab), to protect young children from the deadly infection known as . Worldwide, RSV is the second-leading cause of death during the first year of a newborn’s life, second only to , according to .... + más
Strong RSV vaccine data lifts hopes after years of futility | 10 WBNS
Strong RSV vaccine data lifts hopes after years of futility | ABC News
CBS News USA Politics July 17, 2023
The Food and Drug Administration announced Monday it had approved a new kind of immunization to protect babies from . The drug, nirsevimab, is one of two new options doctors hope could soon prevent the leading cause of hospitalization facing American infants.Outside advisers to... + más
Pfizer says study shows vaccinating pregnant women protects newborns from RSV | ABC7
New York Post USA Life February 23, 2023
A vaccine to protect against severe cases of Respiratory Syncytial Virus could roll out as early as August. Pfizer has developed RSVpreF, a vaccine to prevent severe cases of RSV, and the Food and Drug Administration is reportedly expediting its review approval process. The FDA... + más
Strong RSV vaccine data lifts hopes after years of futility | WPLG Local 10
CNBC USA Health November 11, 2022
Diane Macdonald Stockbyte Getty ImagesEven healthy infants face a considerable risk of hospitalization from respiratory syncytial virus, according to a large European study published Thursday.Dutch and British scientists, in a study published in Lancet Respiratory Medicine,... + más
Forbes USA Business November 04, 2022
Topline The European Commission on Friday approved the first monoclonal antibody to prevent respiratory syncytial virus (RSV) among all infants and newborns, amid a rise of cases of the highly contagious virus, which can pose a danger to infants and older adults. Intensive care... + más
New injection for newborns to protect against RSV approved in Europe | ABC News
ABC News USA Health November 04, 2022
In what could signal the promise of progress to come for newborn infants at risk for RSV, a new monoclonal antibody is being granted approval in Europe as a preventative measure to protect against RSV infection in very young babies -- those most at risk of contracting the virus... + más
About iurex | Privacy Policy | Disclaimer |